Document Classification

Section Type: RESULTS

Text: Compared with the placebo group (N = 105), the sildenafil group (N = 104) at DBPC end of treatment (EOT) had significantly more improvement (P < 0. 05) on all SEX-Q, IIEF (except the Sexual Desire domain), QEQ, and SEAR outcomes, more frequent SIAs and EHS 3 (hard enough for penetration but not completely hard) or EHS 4 (completely hard) erections (odds ratio [OR], 2. 52 and 3. 46, respectively), EHS 4 erections four times as often (OR, 6. 41), more men satisfied with treatment (EDITS ; OR, 2. 6), approximately twice as many men with improved erections (GEQ1 ; OR, 5. 8) and ability to have sexual intercourse (GEQ2 ; OR, 5. 4), and GEQ3 scores that indicated better sex (P < 0. 0001).